Glioblastoma Research & The Way Bevacizumab May Work
By Rob Sutter
It's always interesting to learn about the medical advancements which occur outside of the United States. I believe that these possess great potential for the future and I would like to think that they could carry over to other areas of the world as well. This is especially true when it comes to glioblastoma research, or that tied into any kind of brain cancer in general. Bevacizumab may not be the most common name in the world but, in my mind, it is definitely worth learning about.
It's no wonder why this study had focused so much on glioma in the past. For those who don't know, this is seen as the most common growth that is seen within the brain or the spinal cord, difficult to treat by means of surgery. Out of all of the tumors in the world, these make up about 80% of all of them, which goes to show you just how common they are amongst patients. As a result, making sure that treatments are tailored to help them is imperative.
An article that was posted on Medscape reported on glioblastoma research, more specifically the work done thanks to the Japanese Military of Health, Labor, and Welfare and bevacizumab. It seems like malignant cases would be targeted and the usage of chemo, along with radiation, would potentially help patients. You may be interested to know, though, that there have been prior cases as well. This is the kind of news which, in my opinion, is worthy of mention by authorities on the matter, V.A.B.C. included.
I believe that bevacizumab could be stellar, especially when you take into consideration that the United States had utilized it beforehand. The article talked about how it was approved for such usage, even though it was limited to cases which have been deemed recurrent. Another important point to consider are the concerns that it may not provide any fruitful results in the long run, which was a point brought up by the American Society of Clinical Oncology during a meeting that is conducted yearly.
Does all of this mean that better findings are to come? I can only hope that this is the case because I support all of the ideas of glioblastoma research and how they can play into the kind of work done. I believe that ideas can develop but not until more facts are brought into the picture. My only hope is that better results are had because of this approved drug and who is to say that better therapies won't rise to the surface sooner than expected?
It's no wonder why this study had focused so much on glioma in the past. For those who don't know, this is seen as the most common growth that is seen within the brain or the spinal cord, difficult to treat by means of surgery. Out of all of the tumors in the world, these make up about 80% of all of them, which goes to show you just how common they are amongst patients. As a result, making sure that treatments are tailored to help them is imperative.
An article that was posted on Medscape reported on glioblastoma research, more specifically the work done thanks to the Japanese Military of Health, Labor, and Welfare and bevacizumab. It seems like malignant cases would be targeted and the usage of chemo, along with radiation, would potentially help patients. You may be interested to know, though, that there have been prior cases as well. This is the kind of news which, in my opinion, is worthy of mention by authorities on the matter, V.A.B.C. included.
I believe that bevacizumab could be stellar, especially when you take into consideration that the United States had utilized it beforehand. The article talked about how it was approved for such usage, even though it was limited to cases which have been deemed recurrent. Another important point to consider are the concerns that it may not provide any fruitful results in the long run, which was a point brought up by the American Society of Clinical Oncology during a meeting that is conducted yearly.
Does all of this mean that better findings are to come? I can only hope that this is the case because I support all of the ideas of glioblastoma research and how they can play into the kind of work done. I believe that ideas can develop but not until more facts are brought into the picture. My only hope is that better results are had because of this approved drug and who is to say that better therapies won't rise to the surface sooner than expected?
About the Author:
Visit Voices Against Brain Cancer if you are seeking more information about glioblastoma.
By Rob Sutter
It's always interesting to learn about the medical advancements which occur outside of the United States. I believe that these possess great potential for the future and I would like to think that they could carry over to other areas of the world as well. This is especially true when it comes to glioblastoma research, or that tied into any kind of brain cancer in general. Bevacizumab may not be the most common name in the world but, in my mind, it is definitely worth learning about.
It's no wonder why this study had focused so much on glioma in the past. For those who don't know, this is seen as the most common growth that is seen within the brain or the spinal cord, difficult to treat by means of surgery. Out of all of the tumors in the world, these make up about 80% of all of them, which goes to show you just how common they are amongst patients. As a result, making sure that treatments are tailored to help them is imperative.
An article that was posted on Medscape reported on glioblastoma research, more specifically the work done thanks to the Japanese Military of Health, Labor, and Welfare and bevacizumab. It seems like malignant cases would be targeted and the usage of chemo, along with radiation, would potentially help patients. You may be interested to know, though, that there have been prior cases as well. This is the kind of news which, in my opinion, is worthy of mention by authorities on the matter, V.A.B.C. included.
I believe that bevacizumab could be stellar, especially when you take into consideration that the United States had utilized it beforehand. The article talked about how it was approved for such usage, even though it was limited to cases which have been deemed recurrent. Another important point to consider are the concerns that it may not provide any fruitful results in the long run, which was a point brought up by the American Society of Clinical Oncology during a meeting that is conducted yearly.
Does all of this mean that better findings are to come? I can only hope that this is the case because I support all of the ideas of glioblastoma research and how they can play into the kind of work done. I believe that ideas can develop but not until more facts are brought into the picture. My only hope is that better results are had because of this approved drug and who is to say that better therapies won't rise to the surface sooner than expected?
It's no wonder why this study had focused so much on glioma in the past. For those who don't know, this is seen as the most common growth that is seen within the brain or the spinal cord, difficult to treat by means of surgery. Out of all of the tumors in the world, these make up about 80% of all of them, which goes to show you just how common they are amongst patients. As a result, making sure that treatments are tailored to help them is imperative.
An article that was posted on Medscape reported on glioblastoma research, more specifically the work done thanks to the Japanese Military of Health, Labor, and Welfare and bevacizumab. It seems like malignant cases would be targeted and the usage of chemo, along with radiation, would potentially help patients. You may be interested to know, though, that there have been prior cases as well. This is the kind of news which, in my opinion, is worthy of mention by authorities on the matter, V.A.B.C. included.
I believe that bevacizumab could be stellar, especially when you take into consideration that the United States had utilized it beforehand. The article talked about how it was approved for such usage, even though it was limited to cases which have been deemed recurrent. Another important point to consider are the concerns that it may not provide any fruitful results in the long run, which was a point brought up by the American Society of Clinical Oncology during a meeting that is conducted yearly.
Does all of this mean that better findings are to come? I can only hope that this is the case because I support all of the ideas of glioblastoma research and how they can play into the kind of work done. I believe that ideas can develop but not until more facts are brought into the picture. My only hope is that better results are had because of this approved drug and who is to say that better therapies won't rise to the surface sooner than expected?
About the Author:
Visit Voices Against Brain Cancer if you are seeking more information about glioblastoma.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment